Top Stories
The company reported that patients identified as Onclara IO High had a median overall survival of 484 days, compared with 155 days for those with 'low' designation.
Libre Duo and Libre Duo 10 Day monitor glucose and ketone levels every minute to detect changes that could lead to diabetic ketoacidosis.
The open discovery engine for protein structure prediction, design, and biological discovery is built around three releases: ESMC, ESMFold2 and ESM Atlas.
The suite includes the CE-marked LiverPRO algorithm, which assesses fibrosis risk using only age and routine blood markers.
Doctronic's system recommended renewal in 72% of cases, with physicians agreeing in 91% of those reviews.
Conference News
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the latest results from its mission to build Mu...
New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development...
May 28, 2026 Version 1.0 strengthens the fast, confident HDX-MS analysis experience with workflow-focused enhancements, optimized performance, and improved support for mutant analysis, building on col...
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, today unveiled its enhanced, AI-powered imaging solution, within the Me...
SAN DIEGO, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will...
